x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

RealPharma: Conversations with Pharma Pathfinders

For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.

science life sciences

All Episodes

58:11

Ending The Diagnostic Odyssey with Josh Resnikoff

RealPharma: Conversations with Pharma Pathfinders ·

2026/02/17

Ending the Diagnostic Odyssey: Rare Disease, Employers & Reimagining Health PlansHosts: Na-Ri Oh & Ian Wendt Guest: Joshua Resnikoff, Founder & CEO, Sunstone Health Episode Overview What if the biggest innovation in rare disease wasn’t a new drug—but a new way to navigate the system? In this episode, Na-Ri and Ian sit down with Joshua Resnikoff, biomedical engineer turned founder of Sunstone Health, to explore how employers can fundamentally rethink healthcare spending—while

en-us

59:11

Beyond Survival: Why Empathy Is the Missing...

RealPharma: Conversations with Pharma Pathfinders ·

2026/01/26

🎙️ Beyond Survival: Why Empathy Is the Missing Prescription in PharmaEpisode Summary: In this no-holds-barred conversation, Na-Ri Oh and Ian Wendt sit down with Matthew Zachary—brain cancer survivor, founder of Stupid Cancer, host of Out of Patients, and a relentless disruptor in patient advocacy. At 21, Matthew was diagnosed with brain cancer and faced a life-altering decision: take chemotherapy and lose his identity as a musician, or reject treatment and risk everything. That decision became

en-us

52:54

Breaking the Silence: Why Pharma Needs to Speak Up...

RealPharma: Conversations with Pharma Pathfinders ·

2026/01/12

🎙️ Real Pharma – Episode Title: Breaking the Silence: Why Pharma Needs to Speak UpHosts: Na-Ri Oh & Ian Wendt Guest: Brian Reid, Founder & Principal at Reid Strategic 🔍 Episode Summary: In this episode of Real Pharma, Na-Ri and Ian sit down with Brian Reid—a healthcare communicator, strategist, and former journalist who's worked across government, pharma, and media—to explore a provocative question: Why is the pharmaceutical industry so quiet when it comes to telling its own

en-us

45:54

Formulation as Strategy: Why CDMOs Matter More Than Ever

RealPharma: Conversations with Pharma Pathfinders ·

2025/12/15

Episode Title: Formulation as Strategy: Why CDMOs Matter More Than EverGuest: Elizabeth Hickman, President & CEO, Austin Pharmaceutics Episode Overview In this episode of RealPharma, hosts Nari Oh and Ian Wendt sit down with Elizabeth Hickman, President and CEO of Austin Pharmaceutics, to unpack one of the most critical—and often misunderstood—elements of drug development: formulation and the evolving role of CDMOs. As drug molecules become more complex and solubility challenges grow, CDMOs

en-us

46:48

Untangling the IRA with Emma Cousin

RealPharma: Conversations with Pharma Pathfinders ·

2025/12/08

🎧 Hosts: Na-Ri Oh & Ian Wendt🎓 Special Guests: Emma Cousin (PhD Candidate, Choice Institute – UW), Amos Fung (RealPharma Intern & Student Pharmacist) 🔍 Episode Summary: In this thought-provoking episode, hosts Na-Ri Oh and Ian Wendt sit down with Emma Cousin, a PhD candidate at the Choice Institute, University of Washington, to unpack the real-world implications of the Inflation Reduction Act (IRA)—particularly the Medicare Drug Price Negotiation Program. Joining them is Amos Fung, a

en-us

51:41

Reinventing Cell Therapy with Acoustics

RealPharma: Conversations with Pharma Pathfinders ·

2025/11/24

Reinventing Cell Therapy with Acoustics, Microfluidics & High-Throughput EngineeringIn this episode, hosts Na-Ri Oh and Ian Wendt sit down with Dr. Andrew Gray — immune cell engineer, biotech founder, venture capitalist, and CEO of CellEcho — to explore how a new acoustic-powered gene-delivery platform may redefine the boundaries of cell therapy. The conversation spans the current state of the cell therapy landscape, the persistent barriers to scalability, and why CellEcho’s ASOP platform

en-us

53:31

Food as Medicine: Promise, Pitfalls, and the Politics...

RealPharma: Conversations with Pharma Pathfinders ·

2025/11/10

👩‍🔬👨‍⚕️ Hosts:Na-Ri Oh & Ian Wendt 🎧 Guest: Dr. Ron Shigeta – Biotech visionary, co-founder of IndieBio, and food innovation expert. 🧬 Episode Summary: In this deeply insightful and refreshingly candid episode, Ian and Nari welcome back biotech veteran Dr. Ron Shigeta to explore the evolving landscape where food, health, and biotech collide. From the collapse of the lab-grown meat hype cycle to the challenges of democratizing access to functional food, Ron brings hard truths, historical

en-us

48:27

From Job Search to Power Move: How Top Talent’s...

RealPharma: Conversations with Pharma Pathfinders ·

2025/10/27

🎙 Episode Title: From Job Search to Power Move: How Top Talent’s Playing 2025🧠 Guests: Kristiaan Rawlings, Executive Director at EPM Scientific 🎧 Hosts: Na-Ri Oh & Ian Wendt Episode Summary Layoffs. AI. Resume black holes. The biopharma hiring market feels noisy—and not in a good way. But beneath the doomscrolling, there’s a more nuanced story unfolding. In this episode, Kristiaan Rawlings returns to RealPharma to deliver a data-backed pulse check on the state of hiring across the

en-us

55:13

Where Policy Meets the Pharmacy Counter

RealPharma: Conversations with Pharma Pathfinders ·

2025/10/13

Where Policy Meets the Pharmacy CounterFeaturing Congressman Jake Auchincloss Episode Summary In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Congressman Jake Auchincloss (MA-04) to dissect the tangled web of policy, profit, and politics driving America’s drug pricing system. From pharmacy benefit managers (PBMs) to the politics of tariffs, this discussion explores the push for transparency, fair competition, and sustainable reform in healthcare. Auchincloss, a Marine

en-us

52:51

Conversations, Not Campaigns: The Art of Authentic...

RealPharma: Conversations with Pharma Pathfinders ·

2025/10/06

Episode Title:“Conversations, Not Campaigns: The Art of Authentic Engagement in Healthcare” 🗣️ Episode Summary In this episode, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Colin Hung — healthcare technologist, marketing strategist, and co-founder of the long-running #HCLDR (Healthcare Leadership) Twitter community. Colin shares his journey from biomedical engineering to becoming one of the most respected community builders in digital health. Together, they explore what authentic engagement

en-us

47:55

Building the Highway for AI in Pharma: A Conversation...

RealPharma: Conversations with Pharma Pathfinders ·

2025/09/22

🎙️ Episode Title:Building the Highway for AI in Pharma: A Conversation with Ilya Burkov 📍 Episode Summary In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Dr. Ilya Burkov, Head of AI Cloud at Nebius, to explore the critical infrastructure enabling the AI revolution in drug development. While the headlines often focus on the promise of AI, Ilya brings us backstage—where the real acceleration happens. From GPU scalability and regulatory compliance to synthetic data and

en-us

47:23

Inside the CMC Black Box: A Deep Dive with Reza Oliyai

RealPharma: Conversations with Pharma Pathfinders ·

2025/09/08

🎙️ Episode Title:Inside the CMC Black Box: A Deep Dive with Reza Oliyai 🧾 Show Notes: What exactly is CMC — and why is it behind more FDA rejections than any other category? In this episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with Dr. Reza Oliyai, former SVP of Pharmaceutical & Biologics Operations at Gilead Sciences, and now Founder & CEO of Oliyai Consulting, to demystify the world of Chemistry, Manufacturing, and Controls (CMC). With over three decades of experience

en-us

58:40

Can We Say That? Dara Katcher Levy on the AdPromo...

RealPharma: Conversations with Pharma Pathfinders ·

2025/08/25

In this episode of RealPharma, Ian Wendt and Na-Ri Oh sit down with Dara Katcher Levy, a regulatory attorney at Hyman, Phelps & McNamara, P.C.—widely regarded as one of the nation’s top firms in food and drug law. Dara brings decades of expertise in promotional review, labeling negotiations, and post-market compliance, helping life sciences companies navigate the complex world of FDA regulations.Together, they unpack the most pressing regulatory questions facing biopharma in 2025: DTC

en-us

55:24

From Rock Star to Rare Disease Revolutionary: Casey...

RealPharma: Conversations with Pharma Pathfinders ·

2025/08/11

Episode Title: From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight for His Daughter’s LifeIn this deeply personal and inspiring conversation, hosts Na-Ri Oh and Ian Wendt sit down with Casey McPherson, founder and CEO of AlphaRose Therapeutics—and acclaimed recording artist—to explore how one father’s determination to save his daughter’s life is shaking up the rare disease drug development model. Casey shares his journey from fronting rock bands to founding a biotech company,

en-us

59:39

Behind the PBM Curtain: Antonio Ciaccia Exposes the Game

RealPharma: Conversations with Pharma Pathfinders ·

2025/07/28

Episode Title: Behind the PBM Curtain: Antonio Ciaccia Exposes the Game Show Notes: In this compelling episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt welcome back Antonio Ciaccia, CEO of 46brooklyn Research and President of 3 Axis Advisors, for a hard-hitting discussion on the power and pitfalls of pharmacy benefit managers (PBMs). PBMs remain one of the most opaque and influential forces in healthcare—shaping drug prices, patient access, and payer negotiations—often under the guise of cost

en-us

54:38

340B or Bust: Is This Program Failing the Sick

RealPharma: Conversations with Pharma Pathfinders ·

2025/07/14

🎙️ 340B or Bust: Is This Program Failing the Sick?This week on Real Pharma, hosts Dr. Na-Ri Oh and Ian Wendt dive into the tangled world of 340B with returning guest William “Bill” Sarraille—one of the most respected voices in healthcare law, an active patient advocate, and a rare disease patient himself. The 340B Drug Pricing Program was intended to help vulnerable patients by requiring drug manufacturers to provide discounted medications to covered entities. But as Bill puts it, has the

en-us

56:54

Paging Dr. ChatGPT with Bryce Sady

RealPharma: Conversations with Pharma Pathfinders ·

2025/06/30

Episode Title:Paging Dr. ChaptGPT with Bryce Sady AI Adoption in Healthcare: Navigating the Present and Shaping the Future with Bryce Sady Episode Description: On today's insightful episode of RealPharma, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Bryce Sady, Vice President of Product Development at PSL Group's Medical Education and Communications Division, a veteran innovator at the intersection of healthcare data, education, and AI. Together, they dive into the fascinating landscape of

en-us

54:12

Hiring Heat Check: What’s Hot in Biotech + Pharma...

RealPharma: Conversations with Pharma Pathfinders ·

2025/06/16

Episode Title: “Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025”🎙️ Hosts: Ian Wendt & Na-Ri Oh 🎧 Guest: Kristiaan Rawlings, Executive Recruiter at EPM Scientific Episode Overview: This week, fan favorite Kristiaan Rawlings returns to RealPharma to give us the raw and real insights on pharma and biotech hiring trends as we hit the midpoint of 2025. From compensation curves and BD boom times to the rise of GLP-1s and the return of oncology, this episode is your ultimate

en-us

59:53

The Future of Biotech

RealPharma: Conversations with Pharma Pathfinders ·

2025/06/02

🎙 Episode Title: The Future of BiotechGuest: Andrew Craig, Founder of Plain English Finance | Author of Our Future is Biotech 📌 Episode Summary In this bold and wide-ranging conversation, Ian Wendt and Na-Ri Oh sit down with Andrew Craig—British investor, entrepreneur, and author—to explore how biotechnology is poised to shape the next century in the same way physics and computing shaped the last. Craig draws on his decades of experience as a London and New York investment banker and as a

en-us

49:25

Rooted in Results: The Future of Functional Medicine...

RealPharma: Conversations with Pharma Pathfinders ·

2025/05/19

🎙 Episode Title: Rooted in Results: The Future of Functional Medicine with Dr. Erica Armstrong 🧬 Episode Summary In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Dr. Erica Armstrong, board-certified family medicine physician and founder of Root Functional Medicine, to explore the promise, challenges, and evolution of functional medicine. Dr. Armstrong discusses how Root’s systems-based, data-driven approach is helping patients uncover the root causes of chronic disease, improve

en-us

55 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter